Your browser doesn't support javascript.
loading
ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.
Liu, Yun; Su, Peng; Zhao, Wuchen; Li, Xin; Yang, Xiao; Fan, Jianing; Yang, Huijie; Yan, Cheng; Mao, Lanzhi; Ding, Yinlu; Zhu, Jian; Niu, Zhiguo; Zhuang, Ting.
Afiliación
  • Liu Y; Xinxiang Key Laboratory of Tumor Migration and Invasion Precision Medicine, Xinxiang Medical University, Xinxiang, Henan Province, China.
  • Su P; Henan Key Laboratory of immunology and targeted therapy, School of Laboratory Medicine, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, School of Laboratory Medicine, Xinxiang Medical University, Xinxiang, Henan Province, China.
  • Zhao W; Department of Pathology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Li X; School of International Education, Xinxiang Medical University, Xinxiang, Henan Province, China.
  • Yang X; Xinxiang Key Laboratory of Tumor Migration and Invasion Precision Medicine, Xinxiang Medical University, Xinxiang, Henan Province, China.
  • Fan J; Henan Key Laboratory of immunology and targeted therapy, School of Laboratory Medicine, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, School of Laboratory Medicine, Xinxiang Medical University, Xinxiang, Henan Province, China.
  • Yang H; Xinxiang Key Laboratory of Tumor Migration and Invasion Precision Medicine, Xinxiang Medical University, Xinxiang, Henan Province, China.
  • Yan C; Henan Key Laboratory of immunology and targeted therapy, School of Laboratory Medicine, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, School of Laboratory Medicine, Xinxiang Medical University, Xinxiang, Henan Province, China.
  • Mao L; Xinxiang Key Laboratory of Tumor Migration and Invasion Precision Medicine, Xinxiang Medical University, Xinxiang, Henan Province, China.
  • Ding Y; Henan Key Laboratory of immunology and targeted therapy, School of Laboratory Medicine, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, School of Laboratory Medicine, Xinxiang Medical University, Xinxiang, Henan Province, China.
  • Zhu J; Department of Pharmacology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
  • Niu Z; School of Medicine, Xinxiang University, Xinxiang, China.
  • Zhuang T; Henan Key Laboratory of immunology and targeted therapy, School of Laboratory Medicine, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, School of Laboratory Medicine, Xinxiang Medical University, Xinxiang, Henan Province, China.
Cancer Sci ; 112(7): 2714-2727, 2021 Jul.
Article en En | MEDLINE | ID: mdl-33939216
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Proteínas Serina-Treonina Quinasas / Proteínas Adaptadoras Transductoras de Señales / Proteínas de Unión al ADN / Neoplasias de la Mama Triple Negativas / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Sci Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Proteínas Serina-Treonina Quinasas / Proteínas Adaptadoras Transductoras de Señales / Proteínas de Unión al ADN / Neoplasias de la Mama Triple Negativas / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Sci Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido